Regulatory
Part:BBa_K3179002:Experience
Designed by: Jiaxian Xu Group: iGEM19_SYSU-CHINA (2019-10-13)
Revision as of 18:30, 19 October 2019 by Bigxushen (Talk | contribs) (→Applications of BBa_K3179002)
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K3179002
During the measurement, we have proved that inhibition efficiency of L7AeO is significantly lower than that of L7Ae, but still higher than the control group. It is probably due to the fact that the structural change of the mutant only resulted in a decrease in the binding efficiency between L7Ae and Kturn structure, but the active site was not completely inactivated. Therefore, L7AeO is still possible to combine with Kturn structure in high concentration, and suppress the translation of mRNA.
User Reviews
UNIQa8b0e207d48fc95a-partinfo-00000000-QINU UNIQa8b0e207d48fc95a-partinfo-00000001-QINU